Reduction of translation initiation factor 4E decreases the malignancy of ras-transformed cloned rat embryo fibroblasts - PubMed (original) (raw)
. 1995 Jan 17;60(2):255-63.
doi: 10.1002/ijc.2910600221.
Affiliations
- PMID: 7829225
- DOI: 10.1002/ijc.2910600221
Reduction of translation initiation factor 4E decreases the malignancy of ras-transformed cloned rat embryo fibroblasts
J R Graff et al. Int J Cancer. 1995.
Abstract
Expression of the T24ras oncogene induces malignancy (tumor growth, invasion and metastasis) in cloned rat embryo fibroblasts (CREF T24). In CREF T24, the rate of phosphorylation of eukaryotic translation initiation factor 4E (eIF-4E) is increased, resulting in increased protein synthesis rates. We have recently shown that reducing the protein levels of eIF-4E in CREF T24 (AS4E line) markedly decreases soft-agar colonization, increases tumor latency periods and increases tumor doubling times without significantly altering monolayer growth. In this study, cells with reduced eIF-4E had delayed and reduced invasiveness and decreased experimental metastasis. Furthermore, reduced eIF-4E levels correlated with decreased expression of the metastasis-associated 92-kDa collagenase type-IV and exon-6 variants of the CD44 adhesion molecule [CD44(6v)]. Reduced eIF-4E levels correlated inversely with increased levels of the putative metastasis-suppressor protein nm23. Cell lines established from AS4E tumors and lung metastases exhibited increased levels of eIF-4E protein and protein synthesis rates compared to the AS4E line. Tumor-derived AS4E had the shortened tumor latency periods of CREF T24 but displayed the slow tumor-growth rates of AS4E. Tumor-derived AS4E exhibited the metastatic capacity of CREF T24 controls. Furthermore, tumor- and lung-nodule-derived AS4E expressed levels of CD44 (6v) and the 92-kDa collagenase type IV comparable to CREF T24 and displayed reduced levels of nm23 relative to AS4E. These results demonstrate that eIF-4E is an important effector molecule involved in oncogenic p21ras-induced malignant transformation.
Similar articles
- Decreasing the level of translation initiation factor 4E with antisense RNA causes reversal of ras-mediated transformation and tumorigenesis of cloned rat embryo fibroblasts.
Rinker-Schaeffer CW, Graff JR, De Benedetti A, Zimmer SG, Rhoads RE. Rinker-Schaeffer CW, et al. Int J Cancer. 1993 Nov 11;55(5):841-7. doi: 10.1002/ijc.2910550525. Int J Cancer. 1993. PMID: 8244582 - Translation of ODC mRNA and polyamine transport are suppressed in ras-transformed CREF cells by depleting translation initiation factor 4E.
Graff JR, De Benedetti A, Olson JW, Tamez P, Casero RA Jr, Zimmer SG. Graff JR, et al. Biochem Biophys Res Commun. 1997 Nov 7;240(1):15-20. doi: 10.1006/bbrc.1997.7592. Biochem Biophys Res Commun. 1997. PMID: 9367873 - eIF-4E expression and its role in malignancies and metastases.
De Benedetti A, Graff JR. De Benedetti A, et al. Oncogene. 2004 Apr 19;23(18):3189-99. doi: 10.1038/sj.onc.1207545. Oncogene. 2004. PMID: 15094768 Review.
Cited by
- Elevated expression of eukaryotic translation initiation factor 4E is associated with proliferation, invasion and acquired resistance to erlotinib in lung cancer.
Li Y, Fan S, Koo J, Yue P, Chen ZG, Owonikoko TK, Ramalingam SS, Khuri FR, Sun SY. Li Y, et al. Cancer Biol Ther. 2012 Mar;13(5):272-80. doi: 10.4161/cbt.18923. Epub 2012 Mar 1. Cancer Biol Ther. 2012. PMID: 22236867 Free PMC article. - The eukaryotic translation initiation factor eIF4E is a direct transcriptional target of NF-κB and is aberrantly regulated in acute myeloid leukemia.
Hariri F, Arguello M, Volpon L, Culjkovic-Kraljacic B, Nielsen TH, Hiscott J, Mann KK, Borden KL. Hariri F, et al. Leukemia. 2013 Oct;27(10):2047-55. doi: 10.1038/leu.2013.73. Epub 2013 Mar 7. Leukemia. 2013. PMID: 23467026 Free PMC article. - Targeting translation dependence in cancer.
Malina A, Cencic R, Pelletier J. Malina A, et al. Oncotarget. 2011 Jan-Feb;2(1-2):76-88. doi: 10.18632/oncotarget.218. Oncotarget. 2011. PMID: 21378410 Free PMC article. Review. - Targeting Mnks for cancer therapy.
Hou J, Lam F, Proud C, Wang S. Hou J, et al. Oncotarget. 2012 Feb;3(2):118-31. doi: 10.18632/oncotarget.453. Oncotarget. 2012. PMID: 22392765 Free PMC article. Review. - Epigenetic activation of a subset of mRNAs by eIF4E explains its effects on cell proliferation.
Mamane Y, Petroulakis E, Martineau Y, Sato TA, Larsson O, Rajasekhar VK, Sonenberg N. Mamane Y, et al. PLoS One. 2007 Feb 21;2(2):e242. doi: 10.1371/journal.pone.0000242. PLoS One. 2007. PMID: 17311107 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous